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Background
Process optimization and control are essential to match
biopharmaceutical market demands. Early-steps in the
development of new processes require screening hun-
dreds of transfected clones in order to select those with
the best expression characteristics, and identifying opti-
mal environmental conditions for these clones to grow
and express the protein of interest. While some culture
systems include in situ analysis of cell density, most
often by optical density or capacitance measurements,
the majority of them still rely on off-line, laborious and
time-consuming protocols for recombinant protein ana-
lysis. Spectroscopic methods have been proposed in lit-
erature to support bioprocesses development, because
they are non-invasive and provide data on multiple
components present in the culture bulks, thereby
increasing information on process performance [1].
Here, we developed a fluorescence-based method for
real-time monitoring of viable cells and antibody titers
in bioreactor cultures, and extended this strategy for
high throughput analysis of cellular productivity in 96-
well plates.
Materials and methods
For high-throughput cellular productivity analysis, three
CHO-K1 cell clones with different IgG4 monoclonal anti-
body specific productivities were grown in 125mL shake
flasks. Cultures were sampled twice a day to assess cellu-
lar growth; cell supernatants were stored at -20°C for
further antibody quantification and fluorescence analysis.
The supernatant samples were distributed into black 96-
well plates and the fluorescence maps were collected in a
spectrofluorometer (Horiba Jobin Yvon) connected to a
microwell plate reader via optical fibers, placed above the
microtiter plate [2]. For real-time monitoring of bioreac-
tor cultures, the same three clones were grown in 650mL
working volume bioreactors. Fluorescence analysis was
performed in situ, with the optical fibres placed inside a
submerged stainless steel probe, incorporating a quartz
lens at the bottom.
Both excitation and emission slit widths were set equal
to 5 nm and integration time was set at 0.5 sec. Fluores-
cence excitation-emission matrix, also called fluorescence
map, was recorded in the excitation range of 285 - 485
nm, with a step of 20 nm, and in the emission range of
305 - 565 nm, with steps of 10 nm, giving a total of 176
excitation/emission wavelength pairs (lex/lem). The
acquisition time of each map is approximately 4.5 min.
Further details are described in the literature [2,3].
Results
The applicability of two dimensional (2D) fluorometry
was studied using three CHO cell clones expressing an
IgG4 to monitor viable cell density and antibody titer in
bioreactor cultures and also in 96-well plates, targeting
high throughput screening of cellular productivity. For
the bioreactor application, the fluorescence analysis of
the culture bulk was performed in situ, whereas for the
96-well plate application the cultures were performed in
shake flasks and only the cell supernatant (without cells)
was analyzed in terms of fluorescence. The three cell
clones grow at similar rates and reach similar maximum
cell densities but produce significantly different antibody
quantities. Comparing bioreactor to shake flask cultures,
all cell clones reached higher cell densities and lower
antibody titers in the former system (Figure 1A-D).
As a result of cell growth and metabolism, significant
changes were observed in all fluorescent regions. The
global relative changes can be seen in Figure 1E-F,
where it is plotted the ratios between fluorescence maps
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collected at late culture stages and maps collected after
inoculation, in both culture systems under study. The
larger changes occurred in the region of the cellular
cofactors NAD(H)P (maximum at lex/lem: 365/455nm),
which increased significantly over culture time. In con-
trast, the fluorescence in the regions of tryptophan
(maximum at lex/lem: 285/365nm) and flavins (maxi-
mum at lex/lem: 465/520) decreased along culture.
As the excitation light or the light emitted by fluoro-
phors can be absorbed or dispersed by cells or other
medium components, the signal that reaches the detec-
tor does not correlate linearly with the fluorophor con-
centration. Related to this, no linear correlations could
be obtained between individual lex/lem pairs and our
target bioprocess variables. Therefore, we adopted a
multivariate statistical method, partial least squares, to
construct the regression models linking the variation
found in the spectra with the off-line measurements of
the target variables. The dataset from both culture sys-
tems was split in two parts: one for calibration and the
other for model validation. Both variables were pre-
dicted with good accuracies in the two configurations
under study (Figure 1A-D). Importantly, the antibody
profiles in the validation data sets could be described
with an average error below 7%. This is a very good
result, particularly because the validation data sets
include concentrations above the ranges used to cali-
brate the models, revealing the extrapolation potential
of the developed models.
Conclusions
Both cell density and secreted antibody could be pre-
dicted with good accuracies in culture supernatant sam-
ples, demonstrating the potential of the method to
effectively analyze cellular productivity in 96-well plate
format. This methodology allows to by-pass the time-
consuming ELISA assays and thus contributing to
shorten early-phases of process development. The same
approach was successfully implemented for in-situ, real-
time monitoring of viable cells and antibody titer in
Figure 1 Correlations between predicted and measured cell density (A, B) or antibody titer (C, D), in 96-well plates or bioreactor cultures, as
indicated. Open circles correspond to calibration data points and full circles correspond to validation data points. The optimum number of
latent variables was selected such that the root mean squared error observed in the validation data set was minimum. For cell density, the best
model structures are composed by 6 or 7 latent variables (LVs), corresponding to average errors of 10% or 9%, in the microtiter plates or
bioreactor cultures, respectively. Larger models of 9 LVs allowed the best description for antibody titer, with average errors below 7%. Contour
plots show the relative fluorescence changes in the map during a culture, analyzed in (E) 96-well plates and (F) in bioreactors. Colors reflect the
magnitude of the ratio between maps from the end of a CHO cell culture and the beginning of the same culture.
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bioreactor cultures, allowing continuous evaluation of
bioprocess performance.
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